Quest for the right Drug
אקספורג' 5 מ"ג/ 80 מ"ג EXFORGE 5 MG/80 MG (AMLODIPINE AS BESYLATE, VALSARTAN)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליות מצופות פילם : FILM COATED TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Summary of the safety profile The safety of Exforge has been evaluated in five controlled clinical studies with 5,175 patients, 2,613 of whom received valsartan in combination with amlodipine. The following adverse reactions were found to be the most frequently occurring or the most significant or severe: nasopharyngitis, influenza, hypersensitivity, headache, syncope, orthostatic hypotension, oedema, pitting oedema, facial oedema, oedema peripheral, fatigue, flushing, asthenia and hot flush. Tabulated list of adverse reactions Adverse reactions have been ranked under headings of frequency using the following convention: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data). MedDRA Adverse reactions Frequency System organ Exforge Amlodipine Valsartan class Infections and Nasopharyngitis Common -- -- infestations Influenza Common -- -- Blood and Haemoglobin and -- -- Not known lymphatic system haematocrit decreased disorders Leukopenia -- Very rare -- Neutropenia -- -- Not known Thrombocytopenia, -- Very rare Not known sometimes with purpura Immune system Hypersensitivity Rare Very rare Not known disorders Metabolism and Hyperglycaemia -- Very rare -- nutrition Hyponatraemia Uncommon -- -- disorders Psychiatric Depression -- Uncommon -- disorders Anxiety Rare -- -- Insomnia/sleep disorders -- Uncommon -- Mood swings -- Uncommon -- Confusion -- Rare -- Nervous system Coordination abnormal Uncommon -- -- disorders Dizziness Uncommon Common -- Dizziness postural Uncommon -- -- Dysgeusia -- Uncommon -- Extrapyramidal syndrome -- Not known -- Headache Common Common -- Hypertonia -- Very rare -- Paraesthesia Uncommon Uncommon -- Peripheral neuropathy, -- Very rare -- neuropathy Somnolence Uncommon Common -- Syncope -- Uncommon -- Tremor -- Uncommon -- Hypoesthesia -- Uncommon -- Eye disorders Visual disturbance Rare Uncommon -- Visual impairment Uncommon Uncommon -- Ear and labyrinth Tinnitus Rare Uncommon -- disorders Vertigo Uncommon -- Uncommon Cardiac disorders Palpitations Uncommon Common -- Syncope Rare -- -- Tachycardia Uncommon -- -- Arrhythmias (including -- Very rare -- bradycardia, ventricular tachycardia, and atrial fibrillation) Myocardial infarction -- Very rare -- Vascular Flushing -- Common -- disorders Hypotension Rare Uncommon -- Orthostatic hypotension Uncommon -- -- Vasculitis -- Very rare Not known Respiratory, Cough Uncommon Very rare Uncommon thoracic and Dyspnoea -- Uncommon -- mediastinal Pharyngolaryngeal pain Uncommon -- -- disorders Rhinitis -- Uncommon -- Gastrointestinal Abdominal discomfort, Uncommon Common Uncommon disorders abdominal pain upper Change of bowel habit -- Uncommon -- Constipation Uncommon -- -- Diarrhoea Uncommon Uncommon -- Dry mouth Uncommon Uncommon -- Dyspepsia -- Uncommon -- Gastritis -- Very rare -- Gingival hyperplasia -- Very rare -- Nausea Uncommon Common -- Pancreatitis -- Very rare -- Vomiting -- Uncommon -- Hepatobiliary Liver function test abnormal, -- Very rare* Not known disorders including blood bilirubin increase Hepatitis -- Very rare -- Intrahepatic cholestasis, -- Very rare -- jaundice Skin and Alopecia -- Uncommon -- subcutaneous Angioedema -- Very rare Not known tissue disorders Dermatitis bullous -- -- Not known Erythema Uncommon -- -- Erythema multiforme -- Very rare -- Exanthema Rare Uncommon -- Hyperhidrosis Rare Uncommon -- Photosensitivity reaction -- Uncommon -- Pruritus Rare Uncommon Not known Purpura -- Uncommon -- Rash Uncommon Uncommon Not known Skin discolouration -- Uncommon -- Urticaria and other forms of -- Very rare -- rash Exfoliative dermatitis -- Very rare -- Stevens-Johnson syndrome -- Very rare -- Quincke oedema -- Very rare -- Toxic Epidermal Necrolysis -- Not known -- Musculoskeletal Arthralgia Uncommon Uncommon -- and connective Back pain Uncommon Uncommon -- tissue disorders Joint swelling Uncommon -- -- Muscle spasm Rare Uncommon -- Myalgia -- Uncommon Not known Ankle swelling -- Common -- Sensation of heaviness Rare -- -- Renal and Blood creatinine increased -- -- Not known urinary disorders Micturition disorder -- Uncommon -- Nocturia -- Uncommon -- Pollakiuria Rare Uncommon -- Polyuria Rare -- -- Renal failure and -- -- Not known impairment Reproductive Impotence -- Uncommon -- system and Erectile dysfunction Rare -- -- breast disorders Gynaecomastia -- Uncommon -- General disorders Asthenia Common Uncommon -- and Discomfort, malaise -- Uncommon -- administration Fatigue Common Common Uncommon site conditions Facial oedema Common -- -- Flushing, hot flush Common -- -- Non cardiac chest pain -- Uncommon -- Oedema Common Common -- Oedema peripheral Common -- -- Pain -- Uncommon -- Pitting oedema Common -- -- Investigations Blood potassium increased -- -- Not known Weight increase -- Uncommon -- Weight decrease -- Uncommon -- * Mostly consistent with cholestasis Additional information on the combination Peripheral oedema, a recognised side effect of amlodipine, was generally observed at a lower incidence in patients who received the amlodipine/valsartan combination than in those who received amlodipine alone. In double-blind, controlled clinical trials, the incidence of peripheral oedema by dose was as follows: % of patients who experienced Valsartan (mg) peripheral oedema 0 40 80 160 320 0 3.0 5.5 2.4 1.6 0.9 Amlodipine (mg) 2.5 8.0 2.3 5.4 2.4 3.9 5 3.1 4.8 2.3 2.1 2.4 10 10.3 NA NA 9.0 9.5 The mean incidence of peripheral oedema evenly weighted across all doses was 5.1% with the amlodipine/valsartan combination. Additional information on the individual components Adverse reactions previously reported with one of the individual components (amlodipine or valsartan) may be potential adverse reactions with Exforge as well, even if not observed in clinical trials or during the post-marketing period. Amlodipine Common Somnolence, dizziness, palpitations, abdominal pain, nausea, ankle swelling. Uncommon Insomnia, mood changes (including anxiety), depression, tremor, dysgeusia, syncope, hypoesthesia, visual disturbance (including diplopia), tinnitus, hypotension, dyspnoea, rhinitis, vomiting, dyspepsia, alopecia, purpura, skin discolouration, hyperhidrosis, pruritus, exanthema, myalgia, muscle cramps, pain, micturition disorder, increased urinary frequency, impotence, gynaecomastia, chest pain, malaise, weight increase, weight decrease. Rare Confusion. Very rare Leukocytopenia, thrombocytopenia, allergic reactions, hyperglycaemia, hypertonia, peripheral neuropathy, myocardial infarction, arrhythmia (including bradycardia, ventricular tachycardia and atrial fibrillation), vasculitis, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, hepatic enzymes increased*, angioedema, erythema multiforme, urticaria, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke oedema, photosensitivity. Not known Toxic Epidermal Necrolysis * mostly consistent with cholestasis Exceptional cases of extrapyramidal syndrome have been reported. Valsartan Not known Decrease in haemoglobin, decrease in haematocrit, neutropenia, thrombocytopenia, increase of serum potassium, elevation of liver function values including increase of serum bilirubin, renal failure and impairment, elevation of serum creatinine, angioedema, myalgia, vasculitis, hypersensitivity including serum sickness. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il/
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לצרכן
04.02.20 - עלון לצרכן אנגלית 04.02.20 - עלון לצרכן עברית 04.02.20 - עלון לצרכן ערבית 11.10.22 - עלון לצרכן עברית 07.06.23 - עלון לצרכן אנגלית 07.06.23 - עלון לצרכן עברית 07.06.23 - עלון לצרכן ערבית 04.04.24 - עלון לצרכן עברית 14.05.24 - עלון לצרכן אנגלית 13.05.24 - עלון לצרכן ערבית 28.11.11 - החמרה לעלון 25.06.12 - החמרה לעלון 18.07.13 - החמרה לעלון 22.06.15 - החמרה לעלון 04.02.20 - החמרה לעלון 04.04.23 - החמרה לעלון 04.04.24 - החמרה לעלוןלתרופה במאגר משרד הבריאות
אקספורג' 5 מ"ג/ 80 מ"ג